Recital 14, Regulation (EU) 2024/1052

In forcesince 10 Apr 2024

The opinions and the report of the Authority give sufficient grounds to establish that calcidiol monohydrate when used at levels of up to 10 μg/day in food supplements intended for children from 11 years of age and for adults, including pregnant and lactating women, and when used at levels of up to 5 μg/day in food supplements intended for children from 3 to 10 years of age fulfils the conditions for its placing on the market in accordance with Article 12(1) of Regulation (EU) 2015/2283.